Laboratory of Organic Chemistry, Eidgenössische Technische Hochschule (ETH) Zürich, 8093 Zürich, Switzerland.
Science. 2011 Feb 4;331(6017):589-92. doi: 10.1126/science.1199081.
Confinement of enzymes in protein nanocompartments represents a potentially powerful strategy for controlling catalytic activity in cells. By using a simple electrostatically based tagging system for protein encapsulation, we successfully sequestered HIV protease, a toxic enzyme when produced cytoplasmically, within an engineered lumazine synthase capsid. The growth advantage resulting from protecting the Escherichia coli host from the protease enabled directed evolution of improved capsids. After four rounds of mutagenesis and selection, we obtained a variant with a 5- to 10-fold higher loading capacity than the starting capsid, which permitted efficient growth even at high intracellular concentrations of HIV protease. The superior properties of the evolved capsid can be ascribed to multiple mutations that increase the net negative charge on its luminal surface and thereby enhance engineered Coulombic interactions between host and guest. Such structures could be used for diverse biotechnological applications in living cells.
将酶限制在蛋白质纳米隔室内是一种控制细胞内催化活性的潜在有效策略。通过使用一种简单的基于静电的蛋白质包封标记系统,我们成功地将 HIV 蛋白酶(一种细胞质中产生的有毒酶)隔离在工程化的乳清酸合酶衣壳内。通过保护大肠杆菌宿主免受蛋白酶的侵害,从而获得了生长优势,这使得改良衣壳的定向进化成为可能。经过四轮诱变和选择,我们获得了一个变体,其载量比起始衣壳高 5 到 10 倍,即使在 HIV 蛋白酶的高细胞内浓度下,也能有效地生长。这种进化后的衣壳具有优越的性能,可以归因于多个突变,这些突变增加了其内腔表面的净负电荷,从而增强了宿主和客体之间的工程库仑相互作用。这种结构可以用于活细胞中的多种生物技术应用。